Find out the latest with BOPA, Oncology, and upcoming events
BOPA supported by expertise from the University of York and the National Institute of Health and Care Excellence (NICE) are delighted to announce this Continuing Professional Development (CPD) course…
After ongoing collaboration between BOPA and BSH, the BSH Lymphoma special interest group are seeking to recruit one Pharmacist to their committee. The committee provides a supportive network for clinicians in lymphoma…
CAPhO Oncology Fundamentals Day (OFD) 2025: Saturday, October 18, 2025, 10:00 – 19:00 EDT Are you a pharmacist or technician new to oncology practice? Are you a pharmacy student or…
September marks Gynaecological Cancer Awareness Month (GCAM) Early detection of Ovarian Cancer saves lives and with community pharmacies are on the front line, small conversations can make a life changing difference. Together,…
Members are invited to participate in the Highlights of ISOPP CAPhO Symposium 2025 Webinar hosted by the Canadian Association of Pharmacy in Oncology (CAPhO) and produced in collaboration with the International Society of Oncology Pharmacy…
BOPA have endorsed the UICC & ISOPP Joint Statement ‘Ensuring Quality and Equity in Cancer Treatment’ The alarming findings reported in The Lancet Global Health reveal that approximately one in…
I’m excited to share that the ISOPP International Symposium 2026 is now open for abstract submissions! This 24-hour virtual event takes place on March 20, 2026, and will bring together…
We are inviting healthcare professionals to take part in a short survey as part of the SWITCH study, a research project funded by the National Institute for Health and Care…
The Royal College of Radiologists (RCR) and the Society of Radiographers (SoR) have published a short document that expands on previous proposals for improving funding arrangements to enable equitable access…
Hello All As an Executive Committee we are looking forward to meeting those of you who are signed up to come to the conference in Belfast next month. The BOPA…
Immune checkpoint inhibitors, such as atezolizumab, nivolumab and pembrolizumab have transformed the treatment landscape for many cancers. Cancers such as melanoma and Lynch-syndrome related tumours necessitating immune checkpoint inhibitors are…
British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 21-22 November 2025 | Manchester Central Confirm your free delegate place *free places are only available for registered healthcare…
